Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal Biceps Tendon Repair

December 1, 2023 updated by: Charles S Day, Henry Ford Health System

Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal: A Prospective Randomized Control Trial

The goal of this investigation is to determine if using BFR during postoperative therapy would lead to increased and expedited strength gains. Additionally, the investigators would like to determine if BFR is beneficial in preventing muscle atrophy and fatty infiltration in the setting of bicep tendon tears, due to the altered tension-length relationship following surgery. The study will also look at patient reported outcomes metrics and pain scores to determine if BFR has a significant impact on the patient experience surrounding distal biceps tear and surgical repair

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Detroit, Michigan, United States, 48202
        • Health Ford Health System

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18-80
  • Undergoing distal biceps tendon repair

Exclusion Criteria:

  • Revision Biceps tendon repair,
  • Irrepairable tendon injury,
  • Biceps repairs with biologic augmentation,
  • Patients with concomitant neurovascular injury,
  • Inability to tolerate BFR treatment,
  • Unable to complete full course of physical therapy,
  • Peripheral vascular disease,
  • History of Venous thromboembolism (VTE)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BFR

Patient will use the following rehabilitation protocol while incorporating blood flow restriction therapy:

  • Post-op weeks 0-6: Passive shoulder and wrist Range of Motion (ROM) only

    • Sling immobilization with active wrist and shoulder ROM
    • Active extension of biceps to 30 degrees, No active flexion
  • 6-9 weeks full active extension in brace

    • Maintain wrist and shoulder flexibility
    • Begin rotator cuff/deltoid isometrics, progress active extension in brace
  • Weeks 9-12: Gently advance ROM to tolerance

    • Discontinue sling
    • Begin active flexion and extension against gravity.
    • Advance strength to light resistance, maintain flexibility/ROM
  • Weeks 12-6 months: Gradual return to full ROM and pain free o Begin gradual flexion strengthening and advance as tolerated
Use of a tourniquet set to 50% of limb occlusion pressure while performing post operative physical therapy
No Intervention: Control (no BFR)

patients will use following rehabilitation protocol without the use of blood flow restriction therapy:

  • Post-op weeks 0-6: Passive shoulder and wrist Range of Motion (ROM) only

    • Sling immobilization with active wrist and shoulder ROM
    • Active extension of biceps to 30 degrees, No active flexion
  • 6-9 weeks full active extension in brace

    • Maintain wrist and shoulder flexibility
    • Begin rotator cuff/deltoid isometrics, progress active extension in brace
  • Weeks 9-12: Gently advance ROM to tolerance

    • Discontinue sling
    • Begin active flexion and extension against gravity.
    • Advance strength to light resistance, maintain flexibility/ROM
  • Weeks 12-6 months: Gradual return to full ROM and pain free o Begin gradual flexion strengthening and advance as tolerated

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength
Time Frame: 1 week post-operatively
measured via dynamometer (pounds)
1 week post-operatively
Strength
Time Frame: 6 weeks post-operatively
measured via dynamometer (pounds)
6 weeks post-operatively
Strength
Time Frame: 3 months post-operatively
measured via dynamometer (pounds)
3 months post-operatively
Strength
Time Frame: 6 months post-operatively
measured via dynamometer (pounds)
6 months post-operatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of Motion
Time Frame: 1 week post-operatively
via goniometer (degrees)
1 week post-operatively
Range of Motion
Time Frame: 6 week post-operatively
via goniometer (degrees)
6 week post-operatively
Range of Motion
Time Frame: 3 months post-operatively
via goniometer (degrees)
3 months post-operatively
Range of Motion
Time Frame: 6 months post-operatively
via goniometer (degrees)
6 months post-operatively
Perceived Pain
Time Frame: 1 week post-operatively
via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)
1 week post-operatively
Perceived Pain
Time Frame: 6 week post-operatively
via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)
6 week post-operatively
Perceived Pain
Time Frame: 3 months post-operatively
via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)
3 months post-operatively
Perceived Pain
Time Frame: 6 months post-operatively
via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)
6 months post-operatively
Patient reported outcome scores
Time Frame: 1 week post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score
1 week post-operatively
Patient reported outcome scores
Time Frame: 1 week post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score
1 week post-operatively
Patient reported outcome scores
Time Frame: 1 week post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score
1 week post-operatively
Patient reported outcome scores
Time Frame: 6 week post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score
6 week post-operatively
Patient reported outcome scores
Time Frame: 6 week post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score
6 week post-operatively
Patient reported outcome scores
Time Frame: 6 week post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score
6 week post-operatively
Patient reported outcome scores
Time Frame: 3 months post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score
3 months post-operatively
Patient reported outcome scores
Time Frame: 3 months post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score
3 months post-operatively
Patient reported outcome scores
Time Frame: 3 months post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score
3 months post-operatively
Patient reported outcome scores
Time Frame: 6 months post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score
6 months post-operatively
Patient reported outcome scores
Time Frame: 6 months post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score
6 months post-operatively
Patient reported outcome scores
Time Frame: 6 months post-operatively
via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score
6 months post-operatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2020

Primary Completion (Actual)

August 15, 2021

Study Completion (Actual)

September 15, 2021

Study Registration Dates

First Submitted

July 28, 2020

First Submitted That Met QC Criteria

August 4, 2020

First Posted (Actual)

August 7, 2020

Study Record Updates

Last Update Posted (Estimated)

December 8, 2023

Last Update Submitted That Met QC Criteria

December 1, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Henry - IRB00000253

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bicep Tendon Rupture

Clinical Trials on Blood Flow Restriction Therapy

3
Subscribe